CVEvulnerability
CVE-2026-100584
5.4 MEDIUM
Official page ↗
- Status
- Deferred
- Published
- 2026-09-26
- Last modified
- 2026-10-05
- Assigner
- [email protected]
- CVSS 4.0 ([email protected])
- 5.4 MEDIUM — CVSS:4.0/AV:L/AC:H/AT:P/PR:L/UI:P/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
- CVSS 3.1 ([email protected])
- 6.7 MEDIUM — CVSS:3.1/AV:L/AC:H/PR:L/UI:R/S:U/C:H/I:H/A:H
- Weaknesses
- CWE-426
Description
OpenClaw is an npm-distributed agent runtime. In versions >= 2026.2.26 and < 2026.7.1, PowerShell command analysis on Windows hosts running in exec allowlist mode could approve an exact executable resolved from PATH but subsequently execute a same-named executable located in the workspace directory. If lower-trust content can place an executable with an approved basename into an agent-writable workspace and steer an approved PowerShell command that uses a bare executable name, OpenClaw may run the workspace file instead of the allowlisted path, executing arbitrary code with the privileges of the Gateway or node-host user. The issue does not require replacement of the approved executable itself. Version 2026.7.1 contains a fix; as a workaround, avoid bare executable names in approved PowerShell commands and keep executable files out of agent-writable workspaces.
Related
Weakness · CWE (1)
- CWE-426 Untrusted Search Path weakness